

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * mucosal immune response (GO:0002385) | 8.53899165 |
| 2 | response to peptidoglycan (GO:0032494) | 8.25951287 |
| 3 | oxygen transport (GO:0015671) | 8.11070520 |
| 4 | angiotensin maturation (GO:0002003) | 8.00921883 |
| 5 | * organ or tissue specific immune response (GO:0002251) | 7.99867176 |
| 6 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 7.91586381 |
| 7 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 7.91586381 |
| 8 | * response to fungus (GO:0009620) | 7.65935624 |
| 9 | detection of bacterium (GO:0016045) | 7.18325116 |
| 10 | detection of other organism (GO:0098543) | 7.16583741 |
| 11 | protoporphyrinogen IX metabolic process (GO:0046501) | 7.12975974 |
| 12 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 6.87405140 |
| 13 | gas transport (GO:0015669) | 6.85582858 |
| 14 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 6.70462726 |
| 15 | cellular extravasation (GO:0045123) | 6.50355063 |
| 16 | vitamin A metabolic process (GO:0006776) | 5.99864510 |
| 17 | regulation of bile acid biosynthetic process (GO:0070857) | 5.89848438 |
| 18 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.86560577 |
| 19 | hemoglobin metabolic process (GO:0020027) | 5.84503793 |
| 20 | flavonoid metabolic process (GO:0009812) | 5.79742666 |
| 21 | neutrophil activation (GO:0042119) | 5.63464134 |
| 22 | * cell killing (GO:0001906) | 5.53878765 |
| 23 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.51506956 |
| 24 | digestive system process (GO:0022600) | 5.50102650 |
| 25 | neutrophil activation involved in immune response (GO:0002283) | 5.50055452 |
| 26 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 5.42186116 |
| 27 | negative regulation of interleukin-8 production (GO:0032717) | 5.41827898 |
| 28 | negative regulation of growth of symbiont in host (GO:0044130) | 5.33781627 |
| 29 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 5.33781627 |
| 30 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 5.33781627 |
| 31 | regulation of growth of symbiont in host (GO:0044126) | 5.33781627 |
| 32 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 5.26968165 |
| 33 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 5.17484085 |
| 34 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.17038499 |
| 35 | granulocyte activation (GO:0036230) | 5.16504871 |
| 36 | actin filament depolymerization (GO:0030042) | 5.14335473 |
| 37 | * defense response to Gram-positive bacterium (GO:0050830) | 5.09130298 |
| 38 | virion attachment to host cell (GO:0019062) | 5.05288605 |
| 39 | adhesion of symbiont to host cell (GO:0044650) | 5.05288605 |
| 40 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 5.04402691 |
| 41 | drug catabolic process (GO:0042737) | 4.98853321 |
| 42 | porphyrin-containing compound biosynthetic process (GO:0006779) | 4.94045886 |
| 43 | transepithelial transport (GO:0070633) | 4.84622301 |
| 44 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.81201991 |
| 45 | NADH metabolic process (GO:0006734) | 4.77998992 |
| 46 | intestinal epithelial cell development (GO:0060576) | 4.77980079 |
| 47 | regulation of respiratory burst (GO:0060263) | 4.75045088 |
| 48 | superoxide anion generation (GO:0042554) | 4.74613062 |
| 49 | glucose 6-phosphate metabolic process (GO:0051156) | 4.74158644 |
| 50 | detection of external biotic stimulus (GO:0098581) | 4.67309033 |
| 51 | * antibacterial humoral response (GO:0019731) | 4.65991975 |
| 52 | sperm capacitation (GO:0048240) | 4.65801087 |
| 53 | membrane repolarization during action potential (GO:0086011) | 4.64750182 |
| 54 | * antimicrobial humoral response (GO:0019730) | 4.58991761 |
| 55 | * disruption of cells of other organism (GO:0044364) | 4.49600239 |
| 56 | * killing of cells of other organism (GO:0031640) | 4.49600239 |
| 57 | urea metabolic process (GO:0019627) | 4.49213011 |
| 58 | urea cycle (GO:0000050) | 4.49213011 |
| 59 | leukocyte aggregation (GO:0070486) | 4.45396912 |
| 60 | imidazole-containing compound metabolic process (GO:0052803) | 4.44744036 |
| 61 | detection of biotic stimulus (GO:0009595) | 4.43373190 |
| 62 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 4.43296975 |
| 63 | * defense response to fungus (GO:0050832) | 4.41135869 |
| 64 | regulation of triglyceride catabolic process (GO:0010896) | 4.35616272 |
| 65 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.35026552 |
| 66 | tetrapyrrole biosynthetic process (GO:0033014) | 4.27935566 |
| 67 | regulation of natural killer cell differentiation (GO:0032823) | 4.26753255 |
| 68 | regulation of cholesterol esterification (GO:0010872) | 4.26062953 |
| 69 | lipoprotein metabolic process (GO:0042157) | 4.25615563 |
| 70 | plasma lipoprotein particle assembly (GO:0034377) | 4.22921897 |
| 71 | bicarbonate transport (GO:0015701) | 4.20075148 |
| 72 | heme biosynthetic process (GO:0006783) | 4.19991621 |
| 73 | protein-lipid complex assembly (GO:0065005) | 4.08861340 |
| 74 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.07982047 |
| 75 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.07982047 |
| 76 | adhesion of symbiont to host (GO:0044406) | 4.04306427 |
| 77 | * intracellular estrogen receptor signaling pathway (GO:0030520) | 4.01198414 |
| 78 | modified amino acid transport (GO:0072337) | 3.99715139 |
| 79 | nitrogen cycle metabolic process (GO:0071941) | 3.98492720 |
| 80 | phospholipid efflux (GO:0033700) | 3.97351485 |
| 81 | * defense response to bacterium (GO:0042742) | 3.96891675 |
| 82 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.95484426 |
| 83 | response to host immune response (GO:0052572) | 3.95484426 |
| 84 | erythrocyte maturation (GO:0043249) | 3.94841239 |
| 85 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.89904914 |
| 86 | response to hepatocyte growth factor (GO:0035728) | 3.89904914 |
| 87 | response to methylmercury (GO:0051597) | 3.89658831 |
| 88 | diacylglycerol metabolic process (GO:0046339) | 3.88719047 |
| 89 | erythrocyte development (GO:0048821) | 3.87328932 |
| 90 | porphyrin-containing compound metabolic process (GO:0006778) | 3.87255611 |
| 91 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.86578492 |
| 92 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.85346802 |
| 93 | hydrogen peroxide catabolic process (GO:0042744) | 3.85294567 |
| 94 | ethanol metabolic process (GO:0006067) | 3.82607391 |
| 95 | myeloid cell development (GO:0061515) | 3.81569050 |
| 96 | regulation of cellular extravasation (GO:0002691) | 3.80715185 |
| 97 | bile acid and bile salt transport (GO:0015721) | 3.79639865 |
| 98 | regulation of cholesterol homeostasis (GO:2000188) | 3.77888834 |
| 99 | cholesterol homeostasis (GO:0042632) | 3.77733667 |
| 100 | sterol homeostasis (GO:0055092) | 3.74488098 |
| 101 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.74327268 |
| 102 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.74327268 |
| 103 | fructose metabolic process (GO:0006000) | 3.72681449 |
| 104 | sulfate transmembrane transport (GO:1902358) | 3.72584361 |
| 105 | negative regulation of interleukin-6 production (GO:0032715) | 3.71515410 |
| 106 | primary alcohol catabolic process (GO:0034310) | 3.70552207 |
| 107 | homocysteine metabolic process (GO:0050667) | 3.64955608 |
| 108 | transcytosis (GO:0045056) | 3.57321585 |
| 109 | proline biosynthetic process (GO:0006561) | 3.56799432 |
| 110 | sterol transport (GO:0015918) | 3.56484626 |
| 111 | cholesterol transport (GO:0030301) | 3.56484626 |
| 112 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.56303366 |
| 113 | response to host (GO:0075136) | 3.56303366 |
| 114 | response to host defenses (GO:0052200) | 3.56303366 |
| 115 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 3.55702322 |
| 116 | digestion (GO:0007586) | 3.54445003 |
| 117 | neutrophil mediated immunity (GO:0002446) | 3.54286125 |
| 118 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.53481347 |
| 119 | cholesterol efflux (GO:0033344) | 3.52921263 |
| 120 | * response to bacterium (GO:0009617) | 3.51068394 |
| 121 | respiratory burst (GO:0045730) | 3.46939100 |
| 122 | phagosome maturation (GO:0090382) | 3.46233922 |
| 123 | regulation of digestive system process (GO:0044058) | 3.44741071 |
| 124 | hormone catabolic process (GO:0042447) | 3.41672560 |
| 125 | positive regulation of digestive system process (GO:0060456) | 3.41359225 |
| 126 | heme metabolic process (GO:0042168) | 3.37152048 |
| 127 | filopodium assembly (GO:0046847) | 3.36237902 |
| 128 | regulation of mast cell degranulation (GO:0043304) | 3.32826697 |
| 129 | cellular response to interleukin-6 (GO:0071354) | 3.31982303 |
| 130 | * modification of morphology or physiology of other organism (GO:0035821) | 3.31678295 |
| 131 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.29728511 |
| 132 | drinking behavior (GO:0042756) | 3.26633197 |
| 133 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 3.26436556 |
| 134 | phenylpropanoid metabolic process (GO:0009698) | 3.25620183 |
| 135 | lipoprotein transport (GO:0042953) | 3.23542179 |
| 136 | sulfation (GO:0051923) | 3.21442215 |
| 137 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.19093414 |
| 138 | sulfur compound transport (GO:0072348) | 3.19078748 |
| 139 | O-glycan processing (GO:0016266) | 3.18891238 |
| 140 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.18043877 |
| 141 | neutrophil chemotaxis (GO:0030593) | 3.16822860 |
| 142 | endocrine pancreas development (GO:0031018) | 3.15739150 |
| 143 | negative regulation of cholesterol transport (GO:0032375) | 3.15057472 |
| 144 | negative regulation of sterol transport (GO:0032372) | 3.15057472 |
| 145 | leukotriene biosynthetic process (GO:0019370) | 3.14371582 |
| 146 | positive regulation of osteoblast proliferation (GO:0033690) | 3.13975066 |
| 147 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.13613987 |
| 148 | thyroid hormone metabolic process (GO:0042403) | 3.11660415 |
| 149 | desmosome organization (GO:0002934) | 3.11186452 |
| 150 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.11117491 |
| 151 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.10706060 |
| 152 | peptide hormone processing (GO:0016486) | 3.10038597 |
| 153 | cellular glucuronidation (GO:0052695) | 3.10006959 |
| 154 | megakaryocyte development (GO:0035855) | 3.09573007 |
| 155 | cytidine metabolic process (GO:0046087) | 3.09404472 |
| 156 | cytidine catabolic process (GO:0006216) | 3.09404472 |
| 157 | cytidine deamination (GO:0009972) | 3.09404472 |
| 158 | neutrophil migration (GO:1990266) | 3.08960111 |
| 159 | citrulline biosynthetic process (GO:0019240) | 3.06722105 |
| 160 | leukocyte degranulation (GO:0043299) | 3.06261781 |
| 161 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.05150616 |
| 162 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.05017399 |
| 163 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.03659062 |
| 164 | trophectodermal cell differentiation (GO:0001829) | 3.03212737 |
| 165 | regulation of leukocyte degranulation (GO:0043300) | 3.03104970 |
| 166 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.02385505 |
| 167 | phospholipid homeostasis (GO:0055091) | 3.01306629 |
| 168 | sulfate transport (GO:0008272) | 3.00812113 |
| 169 | regulation of vitamin metabolic process (GO:0030656) | 3.00550519 |
| 170 | drug metabolic process (GO:0017144) | 3.00080128 |
| 171 | activated T cell proliferation (GO:0050798) | 2.96012892 |
| 172 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.94285742 |
| 173 | leukotriene metabolic process (GO:0006691) | 2.93727755 |
| 174 | mast cell activation (GO:0045576) | 2.92655497 |
| 175 | regulation of mast cell activation (GO:0033003) | 2.90472125 |
| 176 | regulation of female gonad development (GO:2000194) | 2.86311542 |
| 177 | granulocyte migration (GO:0097530) | 2.84215968 |
| 178 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.78769650 |
| 179 | pentose-phosphate shunt (GO:0006098) | 2.75514713 |
| 180 | regulation of regulated secretory pathway (GO:1903305) | 2.74784438 |
| 181 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.73370303 |
| 182 | regulation of response to osmotic stress (GO:0047484) | 2.72750984 |
| 183 | response to interleukin-6 (GO:0070741) | 2.70502545 |
| 184 | regulation of interleukin-8 production (GO:0032677) | 2.69826523 |
| 185 | modification by host of symbiont morphology or physiology (GO:0051851) | 2.69123786 |
| 186 | defense response to Gram-negative bacterium (GO:0050829) | 2.67850633 |
| 187 | regulation of erythrocyte differentiation (GO:0045646) | 2.67463407 |
| 188 | hydrogen peroxide metabolic process (GO:0042743) | 2.66292994 |
| 189 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.65355804 |
| 190 | myeloid leukocyte mediated immunity (GO:0002444) | 2.65293660 |
| 191 | response to muramyl dipeptide (GO:0032495) | 2.65195930 |
| 192 | intestinal absorption (GO:0050892) | 12.4047278 |
| 193 | * innate immune response in mucosa (GO:0002227) | 10.4604428 |
| 194 | intestinal cholesterol absorption (GO:0030299) | 10.3789104 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 6.40720606 |
| 2 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 4.41349407 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.17373998 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.88924680 |
| 5 | GATA1_19941826_ChIP-Seq_K562_Human | 3.86561068 |
| 6 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.85349706 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.85290775 |
| 8 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.72979455 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.51596058 |
| 10 | VDR_24763502_ChIP-Seq_THP-1_Human | 3.48416800 |
| 11 | GATA4_25053715_ChIP-Seq_YYC3_Human | 3.45343944 |
| 12 | GATA6_25053715_ChIP-Seq_YYC3_Human | 3.31702908 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.18800266 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.13524657 |
| 15 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.05052508 |
| 16 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.97771375 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.83438079 |
| 18 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.80129091 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.78289857 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 2.78142746 |
| 21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.77712849 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.75750838 |
| 23 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.65464407 |
| 24 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.62109166 |
| 25 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.60447379 |
| 26 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.52787079 |
| 27 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.48147343 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.41870532 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.41066309 |
| 30 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.40005406 |
| 31 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.34686306 |
| 32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.34562645 |
| 33 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.33463411 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.32333165 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.29944517 |
| 36 | SPI1_23127762_ChIP-Seq_K562_Human | 2.22527227 |
| 37 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.22285937 |
| 38 | MYC_22102868_ChIP-Seq_BL_Human | 2.16996777 |
| 39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.16343169 |
| 40 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.12561452 |
| 41 | UTX_26944678_Chip-Seq_JUKART_Human | 2.10834402 |
| 42 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.09749989 |
| 43 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.09581346 |
| 44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08448360 |
| 45 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.07184741 |
| 46 | MAF_26560356_Chip-Seq_TH1_Human | 2.06910002 |
| 47 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.05654965 |
| 48 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 10.4934394 |
| 49 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.96746918 |
| 50 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.96716025 |
| 51 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.96412004 |
| 52 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.92898377 |
| 53 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.92039202 |
| 54 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.88429726 |
| 55 | MYB_26560356_Chip-Seq_TH2_Human | 1.86961936 |
| 56 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.85133159 |
| 57 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.85064286 |
| 58 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.84880444 |
| 59 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.84802319 |
| 60 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.82604496 |
| 61 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.81062662 |
| 62 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.77981632 |
| 63 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.77597087 |
| 64 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.76559078 |
| 65 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.75415546 |
| 66 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.74639955 |
| 67 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.74450049 |
| 68 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.74351758 |
| 69 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.73057667 |
| 70 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.72853859 |
| 71 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.72630672 |
| 72 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.70957791 |
| 73 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.68179133 |
| 74 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.67787596 |
| 75 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.67631811 |
| 76 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65891457 |
| 77 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.64506927 |
| 78 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.62982931 |
| 79 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.62605266 |
| 80 | MYB_26560356_Chip-Seq_TH1_Human | 1.61428079 |
| 81 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.60083623 |
| 82 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.59506141 |
| 83 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.58589508 |
| 84 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.58555784 |
| 85 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.57516822 |
| 86 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.56638387 |
| 87 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.55552635 |
| 88 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.53137818 |
| 89 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.52289922 |
| 90 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.50758789 |
| 91 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.50030493 |
| 92 | ATF3_27146783_Chip-Seq_COLON_Human | 1.49509798 |
| 93 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.48983161 |
| 94 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.42253108 |
| 95 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.40783077 |
| 96 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.40568548 |
| 97 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.39437232 |
| 98 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.38377999 |
| 99 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38150276 |
| 100 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.37742878 |
| 101 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.36702002 |
| 102 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36575149 |
| 103 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.36236699 |
| 104 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.35761842 |
| 105 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34453594 |
| 106 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.34026972 |
| 107 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.33846495 |
| 108 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.33057181 |
| 109 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.32307321 |
| 110 | TP53_16413492_ChIP-PET_HCT116_Human | 1.32125358 |
| 111 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.30137431 |
| 112 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29116057 |
| 113 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29038227 |
| 114 | MAF_26560356_Chip-Seq_TH2_Human | 1.27897562 |
| 115 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.26194982 |
| 116 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.25613293 |
| 117 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20699062 |
| 118 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20333874 |
| 119 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.19816685 |
| 120 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.16996968 |
| 121 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.15887230 |
| 122 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.15849232 |
| 123 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15109582 |
| 124 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.14144868 |
| 125 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.13399402 |
| 126 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12368312 |
| 127 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.10792471 |
| 128 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10335017 |
| 129 | GATA2_19941826_ChIP-Seq_K562_Human | 1.10328410 |
| 130 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.09271491 |
| 131 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.09187830 |
| 132 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.07576941 |
| 133 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.06908467 |
| 134 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.06667326 |
| 135 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.06507990 |
| 136 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06435315 |
| 137 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06298356 |
| 138 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.06240213 |
| 139 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.03793527 |
| 140 | GATA3_26560356_Chip-Seq_TH2_Human | 1.02843716 |
| 141 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.02216018 |
| 142 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02076554 |
| 143 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.00952602 |
| 144 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00003176 |
| 145 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98721184 |
| 146 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.98630045 |
| 147 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97171956 |
| 148 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.95906003 |
| 149 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.95560183 |
| 150 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.94989645 |
| 151 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.94303357 |
| 152 | P68_20966046_ChIP-Seq_HELA_Human | 0.94218710 |
| 153 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.93770933 |
| 154 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.93313558 |
| 155 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91860012 |
| 156 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.91092904 |
| 157 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.90531562 |
| 158 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.90339183 |
| 159 | * FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90175499 |
| 160 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.89152193 |
| 161 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.89152193 |
| 162 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.87930696 |
| 163 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.86815253 |
| 164 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.86795742 |
| 165 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85960986 |
| 166 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.84804965 |
| 167 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.82042545 |
| 168 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.81626510 |
| 169 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.80728264 |
| 170 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.79779674 |
| 171 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.78583296 |
| 172 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.77662601 |
| 173 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.77415988 |
| 174 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.77061396 |
| 175 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.76738073 |
| 176 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.75031774 |
| 177 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.74638933 |
| 178 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.73883663 |
| 179 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.73126577 |
| 180 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.72776929 |
| 181 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.72266698 |
| 182 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.71950965 |
| 183 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71283560 |
| 184 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.71164448 |
| 185 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.68533884 |
| 186 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.66914525 |
| 187 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.66708218 |
| 188 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.64858219 |
| 189 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.63661527 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 9.01845862 |
| 2 | MP0001666_abnormal_nutrient_absorption | 5.05919199 |
| 3 | MP0003303_peritoneal_inflammation | 4.48373551 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 4.24363536 |
| 5 | MP0000462_abnormal_digestive_system | 4.12814795 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 4.04813885 |
| 7 | MP0009785_altered_susceptibility_to | 3.75611705 |
| 8 | MP0009840_abnormal_foam_cell | 3.61272253 |
| 9 | MP0003436_decreased_susceptibility_to | 3.53935807 |
| 10 | MP0005085_abnormal_gallbladder_physiolo | 3.50949755 |
| 11 | MP0009278_abnormal_bone_marrow | 3.43233732 |
| 12 | MP0004264_abnormal_extraembryonic_tissu | 3.32405178 |
| 13 | MP0009379_abnormal_foot_pigmentation | 3.18685523 |
| 14 | MP0002419_abnormal_innate_immunity | 3.14915784 |
| 15 | MP0005025_abnormal_response_to | 3.11530681 |
| 16 | MP0003300_gastrointestinal_ulcer | 3.08384901 |
| 17 | MP0008004_abnormal_stomach_pH | 2.87215573 |
| 18 | MP0003866_abnormal_defecation | 2.74419366 |
| 19 | MP0005397_hematopoietic_system_phenotyp | 2.71201459 |
| 20 | MP0001545_abnormal_hematopoietic_system | 2.71201459 |
| 21 | MP0005083_abnormal_biliary_tract | 2.67220610 |
| 22 | MP0003252_abnormal_bile_duct | 2.66244907 |
| 23 | MP0003183_abnormal_peptide_metabolism | 2.64892226 |
| 24 | MP0000537_abnormal_urethra_morphology | 2.64177841 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.58774633 |
| 26 | MP0003724_increased_susceptibility_to | 2.58404313 |
| 27 | MP0001663_abnormal_digestive_system | 2.33837185 |
| 28 | MP0010329_abnormal_lipoprotein_level | 2.29978726 |
| 29 | MP0001835_abnormal_antigen_presentation | 2.28460541 |
| 30 | MP0010155_abnormal_intestine_physiology | 2.24712865 |
| 31 | MP0005365_abnormal_bile_salt | 2.24678593 |
| 32 | MP0005381_digestive/alimentary_phenotyp | 2.23157415 |
| 33 | MP0000490_abnormal_crypts_of | 2.22948941 |
| 34 | MP0003172_abnormal_lysosome_physiology | 2.21433256 |
| 35 | MP0010352_gastrointestinal_tract_polyps | 2.17799028 |
| 36 | MP0003828_pulmonary_edema | 2.13337766 |
| 37 | MP0000685_abnormal_immune_system | 2.02856053 |
| 38 | MP0001664_abnormal_digestion | 1.97963283 |
| 39 | MP0005000_abnormal_immune_tolerance | 1.95974640 |
| 40 | MP0002420_abnormal_adaptive_immunity | 1.95908898 |
| 41 | MP0008260_abnormal_autophagy | 1.95856098 |
| 42 | MP0008875_abnormal_xenobiotic_pharmacok | 1.94800958 |
| 43 | MP0004019_abnormal_vitamin_homeostasis | 1.93804726 |
| 44 | MP0002822_catalepsy | 1.92871547 |
| 45 | MP0001819_abnormal_immune_cell | 1.92232933 |
| 46 | MP0001873_stomach_inflammation | 1.86688527 |
| 47 | MP0000477_abnormal_intestine_morphology | 1.85518498 |
| 48 | MP0002398_abnormal_bone_marrow | 1.84691216 |
| 49 | MP0003045_fibrosis | 1.78435289 |
| 50 | MP0000538_abnormal_urinary_bladder | 1.76265494 |
| 51 | MP0002452_abnormal_antigen_presenting | 1.75199984 |
| 52 | MP0001533_abnormal_skeleton_physiology | 1.73562172 |
| 53 | MP0001790_abnormal_immune_system | 1.71428179 |
| 54 | MP0005387_immune_system_phenotype | 1.71428179 |
| 55 | MP0002148_abnormal_hypersensitivity_rea | 1.68600797 |
| 56 | MP0000465_gastrointestinal_hemorrhage | 1.66945313 |
| 57 | MP0001800_abnormal_humoral_immune | 1.66091800 |
| 58 | MP0002405_respiratory_system_inflammati | 1.64433733 |
| 59 | MP0002723_abnormal_immune_serum | 1.63477136 |
| 60 | MP0002722_abnormal_immune_system | 1.61212078 |
| 61 | MP0004043_abnormal_pH_regulation | 1.60901349 |
| 62 | MP0000689_abnormal_spleen_morphology | 1.58246196 |
| 63 | MP0009764_decreased_sensitivity_to | 1.54843939 |
| 64 | MP0005058_abnormal_lysosome_morphology | 1.54822956 |
| 65 | MP0001851_eye_inflammation | 1.52781719 |
| 66 | MP0001845_abnormal_inflammatory_respons | 1.51852194 |
| 67 | MP0003075_altered_response_to | 1.50538054 |
| 68 | MP0004808_abnormal_hematopoietic_stem | 1.49415542 |
| 69 | MP0000716_abnormal_immune_system | 1.48195597 |
| 70 | MP0004147_increased_porphyrin_level | 1.47419478 |
| 71 | MP0002138_abnormal_hepatobiliary_system | 1.46706666 |
| 72 | MP0002166_altered_tumor_susceptibility | 1.44962426 |
| 73 | MP0002429_abnormal_blood_cell | 1.44612929 |
| 74 | MP0009333_abnormal_splenocyte_physiolog | 1.43323761 |
| 75 | MP0005076_abnormal_cell_differentiation | 1.41983430 |
| 76 | MP0003787_abnormal_imprinting | 1.37565731 |
| 77 | MP0005084_abnormal_gallbladder_morpholo | 1.37034142 |
| 78 | MP0003693_abnormal_embryo_hatching | 1.35479569 |
| 79 | MP0008872_abnormal_physiological_respon | 1.30036754 |
| 80 | MP0002254_reproductive_system_inflammat | 1.29420527 |
| 81 | MP0002396_abnormal_hematopoietic_system | 1.28982628 |
| 82 | MP0002089_abnormal_postnatal_growth/wei | 1.28357718 |
| 83 | MP0006082_CNS_inflammation | 1.26064597 |
| 84 | MP0002163_abnormal_gland_morphology | 1.25380677 |
| 85 | MP0003123_paternal_imprinting | 1.25025712 |
| 86 | MP0002277_abnormal_respiratory_mucosa | 1.22194007 |
| 87 | MP0002796_impaired_skin_barrier | 1.21707356 |
| 88 | MP0005671_abnormal_response_to | 1.19574617 |
| 89 | MP0000613_abnormal_salivary_gland | 1.14458570 |
| 90 | MP0001485_abnormal_pinna_reflex | 1.12466609 |
| 91 | MP0005448_abnormal_energy_balance | 1.12170710 |
| 92 | MP0001853_heart_inflammation | 1.10797623 |
| 93 | MP0000566_synostosis | 1.09478083 |
| 94 | MP0003119_abnormal_digestive_system | 1.09220228 |
| 95 | MP0000703_abnormal_thymus_morphology | 1.08872221 |
| 96 | MP0005164_abnormal_response_to | 1.08182923 |
| 97 | MP0003763_abnormal_thymus_physiology | 1.07999110 |
| 98 | MP0003705_abnormal_hypodermis_morpholog | 1.06867106 |
| 99 | MP0009780_abnormal_chondrocyte_physiolo | 1.06351259 |
| 100 | MP0006054_spinal_hemorrhage | 1.05656882 |
| 101 | MP0008469_abnormal_protein_level | 1.04442587 |
| 102 | MP0005174_abnormal_tail_pigmentation | 1.02990274 |
| 103 | MP0003806_abnormal_nucleotide_metabolis | 1.02514870 |
| 104 | MP0004185_abnormal_adipocyte_glucose | 1.01851728 |
| 105 | MP0004883_abnormal_blood_vessel | 0.98721011 |
| 106 | MP0009763_increased_sensitivity_to | 0.97029888 |
| 107 | MP0000343_altered_response_to | 0.96981633 |
| 108 | MP0009765_abnormal_xenobiotic_induced | 0.96940372 |
| 109 | MP0009643_abnormal_urine_homeostasis | 0.96892453 |
| 110 | MP0003566_abnormal_cell_adhesion | 0.94358241 |
| 111 | MP0001849_ear_inflammation | 0.93762633 |
| 112 | MP0005332_abnormal_amino_acid | 0.91999931 |
| 113 | MP0009931_abnormal_skin_appearance | 0.90239915 |
| 114 | MP0009053_abnormal_anal_canal | 0.89068669 |
| 115 | MP0002132_abnormal_respiratory_system | 0.88589544 |
| 116 | MP0002006_tumorigenesis | 0.83396093 |
| 117 | MP0000470_abnormal_stomach_morphology | 0.83275353 |
| 118 | MP0000858_altered_metastatic_potential | 0.82969691 |
| 119 | MP0003221_abnormal_cardiomyocyte_apopto | 0.81023483 |
| 120 | MP0003453_abnormal_keratinocyte_physiol | 0.80655522 |
| 121 | MP0009697_abnormal_copulation | 0.80353229 |
| 122 | MP0002998_abnormal_bone_remodeling | 0.79997838 |
| 123 | MP0010678_abnormal_skin_adnexa | 0.79231374 |
| 124 | MP0004270_analgesia | 0.77796554 |
| 125 | MP0002098_abnormal_vibrissa_morphology | 0.77781253 |
| 126 | MP0002118_abnormal_lipid_homeostasis | 0.77456234 |
| 127 | MP0003795_abnormal_bone_structure | 0.76438772 |
| 128 | MP0009384_cardiac_valve_regurgitation | 0.75630839 |
| 129 | MP0005377_hearing/vestibular/ear_phenot | 0.74788927 |
| 130 | MP0003878_abnormal_ear_physiology | 0.74788927 |
| 131 | MP0000609_abnormal_liver_physiology | 0.74785084 |
| 132 | MP0001765_abnormal_ion_homeostasis | 0.71261484 |
| 133 | MP0003315_abnormal_perineum_morphology | 0.69550115 |
| 134 | MP0000678_abnormal_parathyroid_gland | 0.68944628 |
| 135 | MP0003718_maternal_effect | 0.68846866 |
| 136 | MP0005501_abnormal_skin_physiology | 0.68838510 |
| 137 | MP0000249_abnormal_blood_vessel | 0.67295473 |
| 138 | MP0000467_abnormal_esophagus_morphology | 0.67244380 |
| 139 | MP0004510_myositis | 0.66412405 |
| 140 | MP0005166_decreased_susceptibility_to | 0.64499020 |
| 141 | MP0003111_abnormal_nucleus_morphology | 0.64449665 |
| 142 | MP0000516_abnormal_urinary_system | 0.64159685 |
| 143 | MP0005367_renal/urinary_system_phenotyp | 0.64159685 |
| 144 | MP0005390_skeleton_phenotype | 0.63433212 |
| 145 | MP0002095_abnormal_skin_pigmentation | 0.62513605 |
| 146 | MP0004130_abnormal_muscle_cell | 0.62114129 |
| 147 | MP0002019_abnormal_tumor_incidence | 0.60373695 |
| 148 | MP0004947_skin_inflammation | 0.59874841 |
| 149 | MP0003950_abnormal_plasma_membrane | 0.59139132 |
| 150 | MP0001216_abnormal_epidermal_layer | 0.58935944 |
| 151 | MP0005075_abnormal_melanosome_morpholog | 0.58915432 |
| 152 | MP0005636_abnormal_mineral_homeostasis | 0.58478599 |
| 153 | MP0000604_amyloidosis | 0.58177085 |
| 154 | MP0000015_abnormal_ear_pigmentation | 0.57572140 |
| 155 | MP0004381_abnormal_hair_follicle | 0.57452459 |
| 156 | MP0010386_abnormal_urinary_bladder | 0.57166905 |
| 157 | MP0003690_abnormal_glial_cell | 0.56971589 |
| 158 | MP0009115_abnormal_fat_cell | 0.56901064 |
| 159 | MP0000598_abnormal_liver_morphology | 0.56659918 |
| 160 | MP0003868_abnormal_feces_composition | 0.56531081 |
| 161 | MP0002877_abnormal_melanocyte_morpholog | 0.55590597 |
| 162 | MP0005376_homeostasis/metabolism_phenot | 0.55072184 |
| 163 | MP0003448_altered_tumor_morphology | 0.53888377 |
| 164 | MP0005621_abnormal_cell_physiology | 0.53393329 |
| 165 | MP0005319_abnormal_enzyme/_coenzyme | 0.52768053 |
| 166 | MP0001764_abnormal_homeostasis | 0.51490944 |
| 167 | MP0005535_abnormal_body_temperature | 0.51366760 |
| 168 | MP0005408_hypopigmentation | 0.50557153 |
| 169 | MP0002876_abnormal_thyroid_physiology | 0.49203542 |
| 170 | MP0005379_endocrine/exocrine_gland_phen | 0.48467248 |
| 171 | MP0003283_abnormal_digestive_organ | 0.47435080 |
| 172 | MP0000579_abnormal_nail_morphology | 0.46921366 |
| 173 | MP0003191_abnormal_cellular_cholesterol | 0.46264463 |
| 174 | MP0005167_abnormal_blood-brain_barrier | 0.44886198 |
| 175 | MP0002136_abnormal_kidney_physiology | 0.43452577 |
| 176 | MP0002009_preneoplasia | 0.40452343 |
| 177 | MP0009642_abnormal_blood_homeostasis | 0.40033482 |
| 178 | MP0003879_abnormal_hair_cell | 0.38512241 |
| 179 | MP0005248_abnormal_Harderian_gland | 0.36633810 |
| 180 | MP0003656_abnormal_erythrocyte_physiolo | 0.36489653 |
| 181 | MP0003638_abnormal_response/metabolism_ | 0.35415484 |
| 182 | MP0003938_abnormal_ear_development | 0.35255030 |
| 183 | MP0002060_abnormal_skin_morphology | 0.35157654 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypochromic anemia (HP:0001931) | 6.64821848 |
| 2 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 6.41241365 |
| 3 | Microcytic anemia (HP:0001935) | 5.75493325 |
| 4 | Malnutrition (HP:0004395) | 5.72246473 |
| 5 | Ventricular fibrillation (HP:0001663) | 5.67401166 |
| 6 | Acanthocytosis (HP:0001927) | 5.44161184 |
| 7 | Right ventricular cardiomyopathy (HP:0011663) | 5.37381485 |
| 8 | Polycythemia (HP:0001901) | 5.28105877 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 5.20746251 |
| 10 | Conjugated hyperbilirubinemia (HP:0002908) | 5.08685452 |
| 11 | Recurrent abscess formation (HP:0002722) | 4.95277151 |
| 12 | Congenital sensorineural hearing impairment (HP:0008527) | 4.89690608 |
| 13 | Rectal prolapse (HP:0002035) | 4.85565860 |
| 14 | Recurrent bacterial skin infections (HP:0005406) | 4.80183788 |
| 15 | Eczematoid dermatitis (HP:0000976) | 4.76444311 |
| 16 | Toxemia of pregnancy (HP:0100603) | 4.44765092 |
| 17 | Stomatitis (HP:0010280) | 4.36604440 |
| 18 | Paralysis (HP:0003470) | 4.25394659 |
| 19 | Abnormality of macrophages (HP:0004311) | 4.09479336 |
| 20 | Prolonged bleeding time (HP:0003010) | 4.08967543 |
| 21 | Cholelithiasis (HP:0001081) | 4.06214364 |
| 22 | Abnormality of urine glucose concentration (HP:0011016) | 3.92420430 |
| 23 | Glycosuria (HP:0003076) | 3.92420430 |
| 24 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.84507344 |
| 25 | Abnormality of iron homeostasis (HP:0011031) | 3.78043489 |
| 26 | Gastrointestinal dysmotility (HP:0002579) | 3.67054593 |
| 27 | Abdominal distention (HP:0003270) | 3.65543708 |
| 28 | Fat malabsorption (HP:0002630) | 3.64875989 |
| 29 | Abnormal biliary tract morphology (HP:0012440) | 3.64292405 |
| 30 | Abnormal gallbladder morphology (HP:0012437) | 3.63904486 |
| 31 | Abnormality of proline metabolism (HP:0010907) | 3.54281546 |
| 32 | Hydroxyprolinuria (HP:0003080) | 3.54281546 |
| 33 | Chronic obstructive pulmonary disease (HP:0006510) | 3.53575826 |
| 34 | Obstructive lung disease (HP:0006536) | 3.53575826 |
| 35 | Pigmentary retinal degeneration (HP:0001146) | 3.52774559 |
| 36 | Diaphragmatic weakness (HP:0009113) | 3.50173476 |
| 37 | Intrahepatic cholestasis (HP:0001406) | 3.46824278 |
| 38 | Petechiae (HP:0000967) | 3.43624435 |
| 39 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.31364147 |
| 40 | Autoimmune thrombocytopenia (HP:0001973) | 3.27144753 |
| 41 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.20393101 |
| 42 | Abnormality of transition element cation homeostasis (HP:0011030) | 3.18662750 |
| 43 | Male infertility (HP:0003251) | 3.14455639 |
| 44 | Epistaxis (HP:0000421) | 3.14064950 |
| 45 | Urticaria (HP:0001025) | 3.10673306 |
| 46 | Abnormality of vitamin B metabolism (HP:0004340) | 3.08192539 |
| 47 | Poikilocytosis (HP:0004447) | 3.06615972 |
| 48 | Widely patent fontanelles and sutures (HP:0004492) | 3.05744207 |
| 49 | Myositis (HP:0100614) | 3.04721040 |
| 50 | Syncope (HP:0001279) | 3.04684505 |
| 51 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.99532991 |
| 52 | Chronic diarrhea (HP:0002028) | 2.98978180 |
| 53 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.98192468 |
| 54 | Abnormality of the gastric mucosa (HP:0004295) | 2.97136261 |
| 55 | Recurrent skin infections (HP:0001581) | 2.96937585 |
| 56 | Abnormality of chloride homeostasis (HP:0011422) | 2.96000351 |
| 57 | Hyperphosphaturia (HP:0003109) | 2.95939853 |
| 58 | Autoimmune hemolytic anemia (HP:0001890) | 2.91759283 |
| 59 | Mediastinal lymphadenopathy (HP:0100721) | 2.91462288 |
| 60 | Dehydration (HP:0001944) | 2.88923987 |
| 61 | Osteomyelitis (HP:0002754) | 2.87360905 |
| 62 | Pustule (HP:0200039) | 2.84976950 |
| 63 | Gingivitis (HP:0000230) | 2.84873493 |
| 64 | Recurrent fungal infections (HP:0002841) | 2.84405837 |
| 65 | Increased mean platelet volume (HP:0011877) | 2.82827039 |
| 66 | Systemic lupus erythematosus (HP:0002725) | 2.80177781 |
| 67 | Abnormality of vitamin metabolism (HP:0100508) | 2.77753306 |
| 68 | Gastrointestinal infarctions (HP:0005244) | 2.77668126 |
| 69 | Hypolipoproteinemia (HP:0010981) | 2.75158666 |
| 70 | Meningitis (HP:0001287) | 2.74073511 |
| 71 | Abnormal glucose tolerance (HP:0001952) | 2.71755024 |
| 72 | Wide cranial sutures (HP:0010537) | 2.66614307 |
| 73 | Prolonged QT interval (HP:0001657) | 2.64228648 |
| 74 | Amyloidosis (HP:0011034) | 2.63820753 |
| 75 | Abnormality of the gallbladder (HP:0005264) | 2.59178412 |
| 76 | Increased cerebral lipofuscin (HP:0011813) | 2.58150719 |
| 77 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.57699303 |
| 78 | Villous atrophy (HP:0011473) | 2.57699303 |
| 79 | Gingival bleeding (HP:0000225) | 2.53536145 |
| 80 | Woolly hair (HP:0002224) | 2.53204410 |
| 81 | Uterine neoplasm (HP:0010784) | 2.51170918 |
| 82 | Nausea (HP:0002018) | 2.49880254 |
| 83 | Abnormal urine phosphate concentration (HP:0012599) | 2.49819652 |
| 84 | Pili torti (HP:0003777) | 2.49413680 |
| 85 | Abnormality of the fingertips (HP:0001211) | 2.49375571 |
| 86 | Cellulitis (HP:0100658) | 2.47587181 |
| 87 | Recurrent cutaneous fungal infections (HP:0011370) | 2.46777384 |
| 88 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.46777384 |
| 89 | Increased serum ferritin (HP:0003281) | 2.45562475 |
| 90 | Cupped ribs (HP:0000887) | 2.44719529 |
| 91 | Abnormal platelet volume (HP:0011876) | 2.41413029 |
| 92 | Hepatosplenomegaly (HP:0001433) | 2.41134399 |
| 93 | Biliary tract neoplasm (HP:0100574) | 2.39968817 |
| 94 | Hyperglycinuria (HP:0003108) | 2.39744316 |
| 95 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 2.39007797 |
| 96 | Palpitations (HP:0001962) | 2.36802927 |
| 97 | Ventricular arrhythmia (HP:0004308) | 2.35952288 |
| 98 | Fragile skin (HP:0001030) | 2.35838239 |
| 99 | Keratoconjunctivitis sicca (HP:0001097) | 2.35324928 |
| 100 | Episodic fever (HP:0001954) | 2.34570772 |
| 101 | Late onset (HP:0003584) | 2.33769802 |
| 102 | Anorexia (HP:0002039) | 2.32736319 |
| 103 | Abnormal gallbladder physiology (HP:0012438) | 2.32011824 |
| 104 | Cholecystitis (HP:0001082) | 2.32011824 |
| 105 | Increased IgE level (HP:0003212) | 2.31550353 |
| 106 | Granulocytopenia (HP:0001913) | 2.30234490 |
| 107 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.29869310 |
| 108 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.29264683 |
| 109 | Nephrolithiasis (HP:0000787) | 2.28763997 |
| 110 | Menorrhagia (HP:0000132) | 2.25728806 |
| 111 | Thrombophlebitis (HP:0004418) | 2.24228350 |
| 112 | Orchitis (HP:0100796) | 2.23134340 |
| 113 | Thin bony cortex (HP:0002753) | 2.22661353 |
| 114 | Ankyloglossia (HP:0010296) | 2.22398477 |
| 115 | Hypercholesterolemia (HP:0003124) | 2.22296900 |
| 116 | Gastrointestinal carcinoma (HP:0002672) | 2.21280436 |
| 117 | Malignant gastrointestinal tract tumors (HP:0006749) | 2.21280436 |
| 118 | Micronodular cirrhosis (HP:0001413) | 2.20963882 |
| 119 | Recurrent viral infections (HP:0004429) | 2.20121286 |
| 120 | Impaired platelet aggregation (HP:0003540) | 2.19550315 |
| 121 | Abnormal platelet function (HP:0011869) | 2.19550315 |
| 122 | Microretrognathia (HP:0000308) | 2.19268974 |
| 123 | Hyperbilirubinemia (HP:0002904) | 2.18928734 |
| 124 | Abnormal hemoglobin (HP:0011902) | 2.18394646 |
| 125 | Purpura (HP:0000979) | 2.18299474 |
| 126 | Pallor (HP:0000980) | 2.18113593 |
| 127 | Optic neuritis (HP:0100653) | 2.17894281 |
| 128 | Retrobulbar optic neuritis (HP:0100654) | 2.17894281 |
| 129 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.15560376 |
| 130 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.15560376 |
| 131 | Abnormality of glycolipid metabolism (HP:0010969) | 2.15560376 |
| 132 | Hyperammonemia (HP:0001987) | 2.14056339 |
| 133 | Leukocytosis (HP:0001974) | 2.13540186 |
| 134 | Proximal tubulopathy (HP:0000114) | 2.13535186 |
| 135 | Keratoconjunctivitis (HP:0001096) | 2.12810909 |
| 136 | Abnormality of the right ventricle (HP:0001707) | 2.12386579 |
| 137 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.11893759 |
| 138 | Exocrine pancreatic insufficiency (HP:0001738) | 2.09746902 |
| 139 | Reticulocytosis (HP:0001923) | 2.09225692 |
| 140 | Vasculitis (HP:0002633) | 2.08861913 |
| 141 | Abnormality of purine metabolism (HP:0004352) | 2.06170968 |
| 142 | Hyperparathyroidism (HP:0000843) | 2.05544205 |
| 143 | Cutaneous photosensitivity (HP:0000992) | 2.05470044 |
| 144 | Hypertensive crisis (HP:0100735) | 2.05317617 |
| 145 | Posterior subcapsular cataract (HP:0007787) | 2.03490360 |
| 146 | Cheilitis (HP:0100825) | 2.02089222 |
| 147 | Paresthesia (HP:0003401) | 2.00238601 |
| 148 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.00153071 |
| 149 | Hypochromic microcytic anemia (HP:0004840) | 11.5801971 |
| 150 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 10.9463815 |
| 151 | Ileus (HP:0002595) | 10.9262569 |
| 152 | Spontaneous hematomas (HP:0007420) | 1.98844347 |
| 153 | Hypercalciuria (HP:0002150) | 1.96411207 |
| 154 | Goiter (HP:0000853) | 1.95916308 |
| 155 | Encephalitis (HP:0002383) | 1.95761721 |
| 156 | Progressive sensorineural hearing impairment (HP:0000408) | 1.93596282 |
| 157 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.92269559 |
| 158 | Neoplasm of the rectum (HP:0100743) | 1.91111172 |
| 159 | Progressive hearing impairment (HP:0001730) | 1.90608213 |
| 160 | Hemoptysis (HP:0002105) | 1.90603336 |
| 161 | Metabolic acidosis (HP:0001942) | 1.89485914 |
| 162 | Abnormal EKG (HP:0003115) | 1.88860275 |
| 163 | Hypophosphatemia (HP:0002148) | 1.88627148 |
| 164 | Pulmonary infiltrates (HP:0002113) | 1.87539243 |
| 165 | Neoplasm of the small intestine (HP:0100833) | 1.87143428 |
| 166 | Skin rash (HP:0000988) | 1.85814464 |
| 167 | Abnormality of the pericardium (HP:0001697) | 1.84478033 |
| 168 | Symptomatic seizures (HP:0011145) | 1.84028165 |
| 169 | Abnormality of the 1st metacarpal (HP:0010009) | 1.83953960 |
| 170 | Confusion (HP:0001289) | 1.82544490 |
| 171 | Chest pain (HP:0100749) | 1.82326670 |
| 172 | Potter facies (HP:0002009) | 1.82193752 |
| 173 | Facial shape deformation (HP:0011334) | 1.82193752 |
| 174 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.81409087 |
| 175 | Xanthomatosis (HP:0000991) | 1.81406216 |
| 176 | Premature loss of primary teeth (HP:0006323) | 1.81074138 |
| 177 | Hepatocellular carcinoma (HP:0001402) | 1.80286242 |
| 178 | Milia (HP:0001056) | 1.77965759 |
| 179 | Abnormality of reticulocytes (HP:0004312) | 1.77527774 |
| 180 | Abnormal hair laboratory examination (HP:0003328) | 1.77171599 |
| 181 | Splenomegaly (HP:0001744) | 1.76651614 |
| 182 | Hypoparathyroidism (HP:0000829) | 1.75463506 |
| 183 | Abnormality of T cell physiology (HP:0011840) | 1.75009294 |
| 184 | Skin ulcer (HP:0200042) | 1.74345025 |
| 185 | Slow saccadic eye movements (HP:0000514) | 1.72601042 |
| 186 | Azoospermia (HP:0000027) | 1.70065477 |
| 187 | Nonimmune hydrops fetalis (HP:0001790) | 1.69808744 |
| 188 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.68943597 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LMTK2 | 9.54862296 |
| 2 | FRK | 5.82740512 |
| 3 | PRPF4B | 4.98184915 |
| 4 | MAP2K3 | 4.92854644 |
| 5 | PRKG2 | 4.35027354 |
| 6 | MST1R | 3.88437595 |
| 7 | MST4 | 3.27102895 |
| 8 | TAOK2 | 2.66466678 |
| 9 | NME1 | 2.52111691 |
| 10 | GRK6 | 2.36704848 |
| 11 | FES | 2.35942265 |
| 12 | BLK | 2.33775131 |
| 13 | EPHB2 | 2.31723060 |
| 14 | MAP2K6 | 2.21604714 |
| 15 | EPHA2 | 2.16221801 |
| 16 | TNK2 | 2.07395558 |
| 17 | RIPK1 | 2.07276145 |
| 18 | STK39 | 2.05830224 |
| 19 | IRAK4 | 2.03263782 |
| 20 | ZAP70 | 1.99108682 |
| 21 | SYK | 1.97461171 |
| 22 | MAP3K6 | 1.96745196 |
| 23 | NUAK1 | 1.94523961 |
| 24 | TEC | 1.91004238 |
| 25 | CLK1 | 1.83102809 |
| 26 | MAP2K2 | 1.83021948 |
| 27 | BTK | 1.79480300 |
| 28 | TYK2 | 1.73705767 |
| 29 | PIK3CG | 1.72719177 |
| 30 | MAP3K10 | 1.63536209 |
| 31 | MAP3K2 | 1.49917334 |
| 32 | TAOK3 | 1.45633902 |
| 33 | PTK6 | 1.43687109 |
| 34 | PBK | 1.26902394 |
| 35 | MET | 1.23645977 |
| 36 | MAPK12 | 1.23553850 |
| 37 | LYN | 1.23536817 |
| 38 | MAP3K14 | 1.20421506 |
| 39 | MAP3K11 | 1.19607791 |
| 40 | MAP3K5 | 1.19197142 |
| 41 | HCK | 1.17261487 |
| 42 | EIF2AK1 | 1.16131636 |
| 43 | JAK2 | 1.11165786 |
| 44 | MARK3 | 1.09670297 |
| 45 | TTK | 1.07319015 |
| 46 | ERBB2 | 1.05857627 |
| 47 | MAP3K13 | 1.05108982 |
| 48 | ERN1 | 1.03815747 |
| 49 | PTK2B | 1.02684026 |
| 50 | WNK4 | 1.00906298 |
| 51 | IRAK1 | 1.00301505 |
| 52 | MAP3K9 | 0.97007241 |
| 53 | CAMK1D | 0.96635986 |
| 54 | MAP4K1 | 0.91926810 |
| 55 | ITK | 0.89247841 |
| 56 | MAPK7 | 0.88512540 |
| 57 | OXSR1 | 0.86688380 |
| 58 | PIK3CA | 0.85584745 |
| 59 | IKBKE | 0.85502005 |
| 60 | TXK | 0.85228053 |
| 61 | TRPM7 | 0.85042642 |
| 62 | YES1 | 0.84816769 |
| 63 | TESK2 | 0.83218041 |
| 64 | MAP2K4 | 0.82041190 |
| 65 | MAP3K8 | 0.78684517 |
| 66 | MAPK11 | 0.75038414 |
| 67 | TESK1 | 0.73624093 |
| 68 | DMPK | 0.72644658 |
| 69 | PKN2 | 0.71761856 |
| 70 | TRIB3 | 0.71088376 |
| 71 | KIT | 0.71071878 |
| 72 | BMPR2 | 0.71016554 |
| 73 | PDK1 | 0.68516767 |
| 74 | EPHA3 | 0.68032382 |
| 75 | NME2 | 0.67937414 |
| 76 | IRAK2 | 0.67319765 |
| 77 | MAP3K1 | 0.65824975 |
| 78 | JAK1 | 0.65610286 |
| 79 | PTK2 | 0.64367146 |
| 80 | BMX | 0.64358683 |
| 81 | LCK | 0.64306661 |
| 82 | MARK2 | 0.62425136 |
| 83 | RIPK4 | 0.62019048 |
| 84 | RPS6KC1 | 0.58259226 |
| 85 | RPS6KL1 | 0.58259226 |
| 86 | PIM1 | 0.58209542 |
| 87 | PRKAA2 | 0.58013510 |
| 88 | RET | 0.57983467 |
| 89 | JAK3 | 0.57221952 |
| 90 | STK10 | 0.56574524 |
| 91 | HIPK2 | 0.56513671 |
| 92 | DAPK2 | 0.56265667 |
| 93 | KSR2 | 0.55247709 |
| 94 | MAPK4 | 0.55043124 |
| 95 | FER | 0.53782800 |
| 96 | PDK3 | 0.53599787 |
| 97 | PDK4 | 0.53599787 |
| 98 | AURKB | 0.53512280 |
| 99 | IKBKB | 0.52820542 |
| 100 | TAOK1 | 0.51190569 |
| 101 | SMG1 | 0.51167577 |
| 102 | SIK3 | 0.50961760 |
| 103 | DDR2 | 0.50658688 |
| 104 | LATS1 | 0.48958025 |
| 105 | PRKCI | 0.48716445 |
| 106 | CAMK1G | 0.48033545 |
| 107 | RPS6KA6 | 0.46779399 |
| 108 | EPHB1 | 0.46275125 |
| 109 | BRSK2 | 0.45956026 |
| 110 | CSF1R | 0.45377582 |
| 111 | IRAK3 | 0.44905981 |
| 112 | PRKAA1 | 0.44415434 |
| 113 | SGK3 | 0.43465946 |
| 114 | FYN | 0.43284717 |
| 115 | STK11 | 0.42602102 |
| 116 | TTN | 0.42361770 |
| 117 | ROCK1 | 0.41979419 |
| 118 | TGFBR2 | 0.41690348 |
| 119 | MYLK | 0.41517422 |
| 120 | CDK19 | 0.40477568 |
| 121 | MAP2K1 | 0.40071182 |
| 122 | STK4 | 0.38549371 |
| 123 | SIK2 | 0.38382744 |
| 124 | CAMK2B | 0.37439449 |
| 125 | MAP3K7 | 0.36908459 |
| 126 | MATK | 0.36801101 |
| 127 | WNK1 | 0.36755285 |
| 128 | DYRK1B | 0.35669588 |
| 129 | CSNK1E | 0.35140077 |
| 130 | SCYL2 | 0.34864398 |
| 131 | CAMK2G | 0.34236697 |
| 132 | GRK1 | 0.33782348 |
| 133 | KSR1 | 0.33042285 |
| 134 | MAPKAPK2 | 0.32648228 |
| 135 | PAK1 | 0.32097995 |
| 136 | KDR | 0.31475325 |
| 137 | RPS6KA2 | 0.30311104 |
| 138 | TBK1 | 0.28223864 |
| 139 | CAMK2D | 0.28120702 |
| 140 | PRKCA | 0.27620475 |
| 141 | PAK3 | 0.27484520 |
| 142 | CSNK1A1 | 0.26227531 |
| 143 | MAP3K3 | 0.25145568 |
| 144 | CSK | 0.24986796 |
| 145 | TLK1 | 0.24899632 |
| 146 | PRKACG | 0.24657920 |
| 147 | NEK1 | 0.23519146 |
| 148 | CDK12 | 0.23292885 |
| 149 | LRRK2 | 0.22800174 |
| 150 | PDPK1 | 0.21987580 |
| 151 | NEK2 | 0.20761391 |
| 152 | PDK2 | 0.20665448 |
| 153 | RPS6KB2 | 0.20612309 |
| 154 | SRC | 0.20253024 |
| 155 | PRKCQ | 0.19576481 |
| 156 | EEF2K | 0.19403864 |
| 157 | GSK3A | 0.18563947 |
| 158 | AKT2 | 0.18018174 |
| 159 | PAK4 | 0.17098981 |
| 160 | CDK6 | 0.17011776 |
| 161 | AKT3 | 0.16572097 |
| 162 | PRKCB | 0.15156514 |
| 163 | ERBB4 | 0.14950279 |
| 164 | FGR | 0.14526312 |
| 165 | ALK | 0.14495469 |
| 166 | PAK2 | 0.14158560 |
| 167 | RAF1 | 0.13927863 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 5.43269145 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.99751727 |
| 3 | Malaria_Homo sapiens_hsa05144 | 4.02553975 |
| 4 | Mineral absorption_Homo sapiens_hsa04978 | 3.52443186 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.33630336 |
| 6 | Asthma_Homo sapiens_hsa05310 | 3.26976530 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.05579273 |
| 8 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.03448623 |
| 9 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.92944290 |
| 10 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.87713549 |
| 11 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.50974928 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.41634071 |
| 13 | Galactose metabolism_Homo sapiens_hsa00052 | 2.40232713 |
| 14 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.35601554 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.27783083 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 2.24826246 |
| 17 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.23362838 |
| 18 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.22281185 |
| 19 | Bile secretion_Homo sapiens_hsa04976 | 2.17216813 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 2.15113071 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.03319042 |
| 22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.02204608 |
| 23 | Other glycan degradation_Homo sapiens_hsa00511 | 2.00846280 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 1.96502926 |
| 25 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.95671389 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.80321565 |
| 27 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.75138897 |
| 28 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.60915372 |
| 29 | Legionellosis_Homo sapiens_hsa05134 | 1.59527847 |
| 30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.59478668 |
| 31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.58656433 |
| 32 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.58383230 |
| 33 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.56051583 |
| 34 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.55513378 |
| 35 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.54650713 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.52340413 |
| 37 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.46938453 |
| 38 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.46204892 |
| 39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.44927682 |
| 40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.44812100 |
| 41 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.38792303 |
| 42 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.37989116 |
| 43 | Platelet activation_Homo sapiens_hsa04611 | 1.37813358 |
| 44 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.37565186 |
| 45 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.37317865 |
| 46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.28370926 |
| 47 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.24322816 |
| 48 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.22923000 |
| 49 | Pertussis_Homo sapiens_hsa05133 | 1.22634282 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.19394979 |
| 51 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.19376244 |
| 52 | Influenza A_Homo sapiens_hsa05164 | 1.17911989 |
| 53 | Phagosome_Homo sapiens_hsa04145 | 1.16305871 |
| 54 | Hepatitis B_Homo sapiens_hsa05161 | 1.14453799 |
| 55 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.11624749 |
| 56 | Lysosome_Homo sapiens_hsa04142 | 1.10898202 |
| 57 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.09934587 |
| 58 | Amoebiasis_Homo sapiens_hsa05146 | 1.09797582 |
| 59 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.08284882 |
| 60 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.08110560 |
| 61 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.07303510 |
| 62 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.06673952 |
| 63 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.06368476 |
| 64 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.06267996 |
| 65 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.06138128 |
| 66 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.03860012 |
| 67 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.03536353 |
| 68 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.03075580 |
| 69 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.01765422 |
| 70 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.01385972 |
| 71 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.99696528 |
| 72 | Measles_Homo sapiens_hsa05162 | 0.98173145 |
| 73 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.97910030 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.97577160 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.93430570 |
| 76 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.92692076 |
| 77 | Carbon metabolism_Homo sapiens_hsa01200 | 0.92266356 |
| 78 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.91140539 |
| 79 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.89103765 |
| 80 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.87815875 |
| 81 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.86449440 |
| 82 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.85773044 |
| 83 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.84743758 |
| 84 | Tight junction_Homo sapiens_hsa04530 | 0.81844884 |
| 85 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.80161836 |
| 86 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.79287302 |
| 87 | Shigellosis_Homo sapiens_hsa05131 | 0.78056120 |
| 88 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.77765519 |
| 89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.76980796 |
| 90 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.75236551 |
| 91 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.74739781 |
| 92 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.73919048 |
| 93 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73278125 |
| 94 | Apoptosis_Homo sapiens_hsa04210 | 0.72508262 |
| 95 | ABC transporters_Homo sapiens_hsa02010 | 0.71593882 |
| 96 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.69420696 |
| 97 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.68761792 |
| 98 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68197131 |
| 99 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.66621341 |
| 100 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.65544623 |
| 101 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.64408930 |
| 102 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.63743862 |
| 103 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.62438695 |
| 104 | Thyroid cancer_Homo sapiens_hsa05216 | 0.61190680 |
| 105 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.60831489 |
| 106 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60536960 |
| 107 | Ribosome_Homo sapiens_hsa03010 | 0.60345437 |
| 108 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.59999730 |
| 109 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57473385 |
| 110 | Lysine degradation_Homo sapiens_hsa00310 | 0.56090023 |
| 111 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.56026087 |
| 112 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.55981805 |
| 113 | Retinol metabolism_Homo sapiens_hsa00830 | 0.55619441 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55568788 |
| 115 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.55448915 |
| 116 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.55385320 |
| 117 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55380119 |
| 118 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.55372122 |
| 119 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.54997300 |
| 120 | Prostate cancer_Homo sapiens_hsa05215 | 0.53337662 |
| 121 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53214200 |
| 122 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.52491687 |
| 123 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.50482525 |
| 124 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.49736358 |
| 125 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.49309310 |
| 126 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.48827261 |
| 127 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47870388 |
| 128 | Glioma_Homo sapiens_hsa05214 | 0.47401378 |
| 129 | Endocytosis_Homo sapiens_hsa04144 | 0.46521972 |
| 130 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45907534 |
| 131 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.45651618 |
| 132 | Insulin resistance_Homo sapiens_hsa04931 | 0.45552764 |
| 133 | Allograft rejection_Homo sapiens_hsa05330 | 0.45466677 |
| 134 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.44611806 |
| 135 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.43704031 |
| 136 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42801842 |
| 137 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.42103344 |
| 138 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41818787 |
| 139 | HTLV-I infection_Homo sapiens_hsa05166 | 0.41632159 |
| 140 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.41601555 |
| 141 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.41288413 |
| 142 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.41187779 |
| 143 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.40054969 |
| 144 | Alzheimers disease_Homo sapiens_hsa05010 | 0.39956965 |
| 145 | Salmonella infection_Homo sapiens_hsa05132 | 0.38481776 |
| 146 | Bladder cancer_Homo sapiens_hsa05219 | 0.35630356 |
| 147 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.35307101 |
| 148 | Salivary secretion_Homo sapiens_hsa04970 | 0.34901332 |
| 149 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.34530441 |
| 150 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.33504555 |
| 151 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.33277793 |
| 152 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32330928 |
| 153 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.30954369 |
| 154 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.30029802 |
| 155 | Hepatitis C_Homo sapiens_hsa05160 | 0.29773194 |
| 156 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.29170982 |
| 157 | Adherens junction_Homo sapiens_hsa04520 | 0.28947697 |
| 158 | Parkinsons disease_Homo sapiens_hsa05012 | 0.27456480 |
| 159 | Metabolic pathways_Homo sapiens_hsa01100 | 0.27237202 |
| 160 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.26756487 |
| 161 | Insulin secretion_Homo sapiens_hsa04911 | 0.25487219 |
| 162 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.24132173 |
| 163 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.23094669 |
| 164 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.17810204 |
| 165 | Endometrial cancer_Homo sapiens_hsa05213 | 0.16427544 |
| 166 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.14692934 |
| 167 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.14632652 |
| 168 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.12399123 |
| 169 | Renin secretion_Homo sapiens_hsa04924 | 0.11661808 |
| 170 | Huntingtons disease_Homo sapiens_hsa05016 | 0.11136767 |
| 171 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.10950149 |
| 172 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.10117031 |
| 173 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.08296089 |
| 174 | Peroxisome_Homo sapiens_hsa04146 | 0.08281197 |
| 175 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.08080813 |
| 176 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.07238537 |
| 177 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.05670470 |

